Rheumatology Advisor interviewed Edith Williams, MS, PhD, on the topic of promoting diversity in clinical trials.

Emerging evidence points to energy breakdowns inside brain cells as the root of mental illness. This discovery challenges decades of chemical theories and may lead to therapies that restore cellular ...

The triplet therapy of ciforadenant, nivolumab (Opdivo), and ipilimumab (Yervoy) showed acceptable safety but failed to improve efficacy in patients with untreated, advanced clear cell kidney cancer ...

Neuroscientist Gerald Voelbel’s journey from mysterious symptoms to a rare cancer and neurological disorder diagnosis highlights the power of self-advocacy and finding purpose.

Follow-up was done according to EAU guidelines. In 27 patients mIR-371 was evaluated preoperatively and correlated with ...

Creating classroom presentations now takes minutes, not hours. Type a clear prompt, point to a webpage or file, and watch a ...

In this innovation-focused webinar, we’ll explore how syndromic testing is transforming the diagnostic and clinical management of bloodstream infections (BSIs). Featuring real-world ex ...

The event will take place on November 3, 2025 beginning at 10 am ET and will feature presentations by ProQR Management and ...

Bionano Genomics, Inc. (NASDAQ: BNGO) participated in The American Society of Human Genetics (ASHG) conference from October 14–18, 2025 in Boston. The event highlighted the potential for an expanding ...